Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
01/02/2025
Evidence/Notes:

TNR was first reported in relation to autosomal recessive neurodevelopmental disorder, non-progressive with spasticity and transient opisthotonus (NEDSTO) in 2012 (Dufresne et al., PMID: 22730557). Individuals with variants in TNR can present with features such as gross motor delay (specifically in walking), axial hypotonia, peripheral spasticity, opisthotonus, and varying degrees of intellectual disability. Other phenotypes can include speech delay and brain myelination anomalies.

Ten variants (missense, frameshift, nonsense, large deletion) that have been reported in 16 probands in 3 publications (PMIDs: 22730557, 28334938, 32099069) are included in this curation. The mechanism of pathogenicity appears to be loss-of-function (PMID: 22730557). This gene-disease relationship is also supported by experimental evidence such as a mouse model and expression-level evidence (PMIDs: 8626505, 12882316, 15034584). The mouse model shows that TNR-deficient mice have atypical behavior, structural brain anomalies, and impaired learning/memory. Expression-level data from healthy human tissue shows that the gene is expressed specifically in the brain.

In summary, there is definitive evidence supporting the relationship between TNR and autosomal recessive NEDSTO. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cerebral Palsy Gene Curation Expert Panel on January 2, 2025 (SOP Version 11).

PubMed IDs:
8626505 12882316 22730557 28334938 32099069
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.